Friday, 24 October 2014
Last updated 2 hours ago
Sep 17 2012 | 1:37pm ET
A healthcare hedge fund had a second quarter it won't soon forget, jumping more than a quarter on the period.
Palo Alto Investors rose 26.2% between April and June, Insider Monkey reports. The surge is thanks in no small part to Palo Alto's largest holding, Onyx Pharmaceuticals, which makes up almost 17% of the hedge fund's portfolio and which is up 74.5% this year.
Palo Alto also profited from its stakes in Cyberonics Inc.
Sep 22 2014 | 4:15pm ET
"I tell people that everybody likes good news and so if you have good performance that’s wonderful,” explains Mike McKitish of Peddie School's endowment, “but it’s the people that want to talk about the bad news or where they drifted and how they came back and how they stayed to their discipline…” that he wants to hear from. Read more…
Most traders agree that proper risk management is the key to successful trading. However, many traders depend on the deeply flawed measure of standard deviation as a benchmark of risk. Here we put it ...